Expression of an oncogenic K-RAS (K-RASG13D) (Figure 2A, blue arrows), a constitutively guanosine-diphosphate (GDP)-bound form of K-RAS, in T-ALL and AML cell lines leads to a delay in DSB resolution and a more error-prone repair [106]. Here, KRAS is linked to acute myeloid leukemia.